Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT00690469
Eligibility Criteria:
Inclusion Criteria:
* Cases must meet the following criteria:
* Diagnosed with sporadic retinoblastoma (RB) on or after 07/01/2006
* No familial retinoblastoma
* Have permission of physician to contact the parents
* Diagnosed and/or treated at a Children's Oncology Group (COG) institution or \*Wills Eye Hospital
* Controls must meet 1 of the following criteria:
* Mother of a child with unilateral RB
* Father of a child with bilateral RB
* Age-matched non-blood-related child if possible
* Must reside in the U.S. or Canada
* Must have telephone in the home
* Biological parent speaks English or Spanish
* Concurrent treatment on a therapeutic trial is NOT required
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT00690469
Study Brief:
Protocol Section:
NCT00690469